EP2858985
Kristölluð form andrógen viðtakastillis
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
4.6.2013EP published:
18.4.2018EP application number:
13800681.2
EP translation filed:
23.5.2018Grant published:
15.6.2018EPO information:
European Patent Register
Max expiry date:
3.6.2033Expiry date:
3.6.2026Next due date:
30.6.2026
Title:
CRYSTALLINE FORMS OF AN ANDROGEN RECEPTOR MODULATOR
Timeline
Today
4.6.2013EP application
18.4.2018EP Publication
23.5.2018Translation submitted
15.6.2018Registration published
3.6.2026Expires
Owner
Name:
Aragon Pharmaceuticals, Inc.Address:
12780 El Camino Real, Suite 301, 92130, San Diego, CA, US
Name:
Sloan-Kettering Institute for Cancer ResearchAddress:
1275 York Avenue, 10065, New York, NY, US
Inventor
Name:
SMITH, Nicholas, D.Address:
San Diego, CA, US
Name:
HERBERT, Mark, R.Address:
San Diego, CA, US
Name:
OUERFELLI, OuathekAddress:
Fort Lee, NJ, US
Name:
DILHAS, AnnaAddress:
Basel, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201261656888 PDate:
7.6.2012Country:
US
Classification
Categories:
C07D 401/04, A61K 31/4439, A61K 31/4184, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 6.6.2018
Expires: 3.6.2019
Payer: Árnason Faktor
Number: 7
Paid: 8.5.2019
Expires: 3.6.2020
Payer: Árnason Faktor
Number: 8
Paid: 5.5.2020
Expires: 3.6.2021
Payer: Árnason Faktor ehf.
Number: 9
Paid: 11.5.2021
Expires: 3.6.2022
Payer: Árnason Faktor ehf.
Number: 10
Paid: 6.5.2022
Expires: 3.6.2023
Payer: Árnason Faktor ehf.
Number: 11
Paid: 24.5.2023
Expires: 3.6.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 7.5.2024
Expires: 3.6.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 20.5.2025
Expires: 3.6.2026
Payer: Árnason Faktor ehf.